Jinglei Ping, an assistant professor of mechanical and industrial engineering at the University of Massachusetts Amherst, with an adjunct role in biomedical engineering and affiliation with the Institute for Applied Life Sciences, was awarded a $1.9 million, five-year NIH grant to investigate cellular communication.
UCLA researchers have received a grant worth up to $7 million over five years from the National Institute of Allergy and Infectious Diseases to launch a first-in-human clinical trial evaluating whether drugs already used to treat autoimmune diseases can prevent or reverse immune checkpoint inhibitor-induced type 1 diabetes, a rare but often permanent complication of cancer immunotherapy.
